[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509709":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":157,"collaborators":18,"id":159,"slug":18,"hasResults":160,"nctId":161,"briefTitle":162,"officialTitle":163,"acronym":164,"eligibilityCriteria":165,"healthyVolunteers":160,"sex":166,"minAge":167,"maxAge":168,"enrollmentInfo":169,"targetDuration":18,"studyType":172,"phases":173,"briefSummary":175,"conditions":176,"keywords":18,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":182,"completionDateStruct":184,"leadSponsor":186,"locationsCount":187},{"fullName":5,"class":6},"University Hospital, Tours","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Furosemide","EXPERIMENTAL","Injection of 40 mg of Furosemide during 10 minutes after the end of the flexible ureteroscopy for destruction of kidney stones with laser.",[13],"Drug: Furosemide 40 mg",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care","NO_INTERVENTION","Usual care, without injection of Furosemide.",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"DRUG","Furosemide 40 mg",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Marie-Lou LETOUCHE, MD","CONTACT","+33247474665","marielou.letouche@gmail.com",[31,49,63,77,91,105,119,133,144],{"facility":32,"status":33,"city":34,"state":18,"zip":18,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"CHU d'Angers","RECRUITING","Angers","France",{"type":37,"coordinates":38},"Point",[39,40],-0.55202,47.47156,{"lat":40,"lon":39},[43,47],{"name":44,"role":27,"phone":45,"phoneExt":18,"email":46},"Pierre BIGOT","+332 41 35 64 94","pibigot@chu-angers.fr",{"name":44,"role":48,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"facility":50,"status":33,"city":51,"state":18,"zip":18,"country":35,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Hospices Civils de Lyon","Lyon",{"type":37,"coordinates":53},[54,55],4.84789,45.74906,{"lat":55,"lon":54},[58,62],{"name":59,"role":27,"phone":60,"phoneExt":18,"email":61},"Nadia ABID","+33472119675","nadia.abid@chu-lyon.fr",{"name":59,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":64,"status":33,"city":65,"state":18,"zip":18,"country":35,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"CHU de Nice","Nice",{"type":37,"coordinates":67},[68,69],7.26608,43.70313,{"lat":69,"lon":68},[72,76],{"name":73,"role":27,"phone":74,"phoneExt":18,"email":75},"Mathieu DURAND","+33492031637","durand.m@chu-nice.fr",{"name":73,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":78,"status":33,"city":79,"state":18,"zip":18,"country":35,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"CHU de Nîmes","Nîmes",{"type":37,"coordinates":81},[82,83],4.35788,43.83665,{"lat":83,"lon":82},[86,90],{"name":87,"role":27,"phone":88,"phoneExt":18,"email":89},"Stéphane DROUPY","+334 66 68 33 53","stephane.droupy@chu-nimes.fr",{"name":87,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":92,"status":33,"city":93,"state":18,"zip":18,"country":35,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"CHU de Rennes","Rennes",{"type":37,"coordinates":95},[96,97],-1.67431,48.11109,{"lat":97,"lon":96},[100,104],{"name":101,"role":27,"phone":102,"phoneExt":18,"email":103},"Karim BENSALAH","+332 99 28 42 70","charles-karim.BENSALAH@chu-rennes.fr",{"name":101,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":106,"status":33,"city":107,"state":18,"zip":18,"country":35,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"CHU de Rouen","Rouen",{"type":37,"coordinates":109},[110,111],1.09932,49.44313,{"lat":111,"lon":110},[114,118],{"name":115,"role":27,"phone":116,"phoneExt":18,"email":117},"Hugo DUPUIS","+332 32 88 89 90","hugo.dupuis@chu-rouen.fr",{"name":115,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":120,"status":33,"city":121,"state":18,"zip":18,"country":35,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"CHU de Toulouse","Toulouse",{"type":37,"coordinates":123},[124,125],1.44367,43.60426,{"lat":125,"lon":124},[128,132],{"name":129,"role":27,"phone":130,"phoneExt":18,"email":131},"Xavier GAME","+33561323106","game.x@chu-toulouse.fr",{"name":129,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":134,"status":33,"city":121,"state":18,"zip":18,"country":35,"cosmosGeoPoint":135,"geoPoint":137,"contacts":138},"Clinique La Croix du Sud",{"type":37,"coordinates":136},[124,125],{"lat":125,"lon":124},[139,143],{"name":140,"role":27,"phone":141,"phoneExt":18,"email":142},"Christophe ALMERAS","+335 32 02 72 02","c.almeras@gmail.com",{"name":140,"role":48,"phone":18,"phoneExt":18,"email":18},{"facility":145,"status":33,"city":146,"state":18,"zip":18,"country":35,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"CHRU de Tours","Tours",{"type":37,"coordinates":148},[149,150],0.70398,47.39484,{"lat":150,"lon":149},[153,156],{"name":154,"role":27,"phone":155,"phoneExt":18,"email":29},"Marie-Lou LETOUCHE","+336 74 75 71 13",{"name":154,"role":48,"phone":18,"phoneExt":18,"email":18},{"type":158,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100509709",false,"NCT05916963","Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser","FIRESTONES : Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser: a Randomized Controlled Two-parallel Group Multicenter Trial With Blinding Evaluation","FIREStones","Inclusion Criteria:\n\n* Patients ≥ 18 years old and \\\u003C 80 years old\n* With the need to perform a flexible ureteroscopy with destruction of the kidney stones with laser\n* Participants covered by or entitled to social security\n* Written informed consent obtained from the participant\n* Ability for participant to comply with the requirements of the study\n\nExclusion Criteria:\n\n* Persons covered by articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure: guardianship or trusteeship)\n* Contra-indication to Furosemide:\n\n  * Hyper-sensitivity to the active substance or one of the excipients\n  * Hyper-sensitivity to Sulfonamide\n  * Renal failure with oligo-anuria refractory to Furosemide\n  * Hypokalemia \\\u003C 3,5 mmol\u002FL\n  * Severe hyponatremia\n  * Hypovolemia with or without hypotension or dehydration\n  * Ongoing hepatitis, hepatic insufficiency severe and hepatic encephalopathy\n* Patient having Furosemide as usual treatment\n* Patient requiring an injection of Aminoside or Vancomycin before or during the procedure\n* Participation in other interventional research with an investigational drug or medical device","ALL","18 Years","80 Years",{"count":170,"type":171},374,"ESTIMATED","INTERVENTIONAL",[174],"PHASE3","In view of the positive results of the numerous studies conducted on forced diuresis after extra-corporeal lithotripsy, the investigators chose to evaluate forced diuresis by injection of Furosemide associated with intravenous hydration, which has never before been the subject of a specific analysis.",[177],"Kidney Stone","2025-11-18",{"date":180,"type":181},"2025-11-24","ACTUAL",{"date":183,"type":181},"2024-01-04",{"date":185,"type":171},"2026-04-03",{"name":5,"class":6},9]